Rojsajjakul, Teerapat
Selvan, Nithya
De, Bishnu
Rosenberg, Jonathan B.
Kaminsky, Stephen M.
Sondhi, Dolan
Janki, Peter
Crystal, Ronald G.
Mesaros, Clementina
Khanna, Richie
Blair, Ian A.
Funding for this research was provided by:
National Institutes of Health (U01NS114143, R61HL151355, R61HL151355, R61HL151355, R61HL151355, U01NS114143, U01NS114143)
Article History
Received: 21 December 2023
Accepted: 6 April 2024
First Online: 10 April 2024
Competing interests
: N.S., P.J., and R.K. are full-time employees of LEXEO Therapeutics, Inc, S.M.K. and D.S. have equity in LEXEO Therapeutics, Inc, and R.G.C. has equity in and is a consultant for LEXEO Therapeutics, Inc. I.A.B. has paid service/sponsored research agreements with LEXEO Therapeutics, Inc and Design Therapeutics, Inc. The other authors declare no competing interests.